Intero Biosystems
Developing human intestinal organoids for drug and compound testing.
Intero Biosystems is a biotech & life sciences company based in Denver, US, founded in 2024. It has raised $2.3 million in disclosed funding. Its latest round was a Pre-seed of $2.3 million in October 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $2.3M across 1 round. Computed only from sourced rounds.
| Date | Company | Amount | Stage | Lead | Other investors | Sector | Sources |
|---|---|---|---|---|---|---|---|
| $2.3M | Pre-seed | — | — | Biotech & Life Sciences | 1 |
- Intero Biosystems$2.3M
Questions and answers
What does Intero Biosystems do?
Developing human intestinal organoids for drug and compound testing.
How much has Intero Biosystems raised?
Intero Biosystems has raised $2.3 million in disclosed funding across 1 round tracked by OSH.
When and where was Intero Biosystems founded?
Intero Biosystems was founded in 2024 and is based in Denver, US.
Timeline
Founded
Sources
- 1.Intero Biosystems wants drugmakers to test on mini human intestines, not animals — TechCrunch Startups, Oct 14, 2026
- 2.And the winner of Startup Battlefield at Disrupt 2026 is: Intero Biosystems — TechCrunch Startups, Oct 15, 2026